ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Part 3: How to test
PARP inhibition in the treatment of prostate cancer
Prostate cancer screening using prostate-specific antigen, a multiplex blood-tes...
Prof Martin Eklund - Karolinska Institutet, Solna, Sweden
OncoAlert and ecancer weekly round up for July 12- July 18, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invas...
Dr Cosimo De Nunzio - Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Cell free DNA BRAF mutant allele fraction and whole exome sequencing in BRAFV600...
Dr Elena Elez - Vall d'Hebron University Hospital, Barcelona, Spain
New Director of the Cicely Saunders Institute at King’s College London
Prof Richard Harding - King's College London, London, UK
FGFR as a tumour agnostic indicator and its importance in the diagnosis and trea...
Dr Christophe Massard and Prof Eva Compérat
ASCO 2021: Precision and molecular reporting for prostate cancer
Prof Eleni Efstathiou - Houston Methodist Cancer Center, Houston, USA
Neo-AEGIS: Preliminary results of phase III RCT of CROSS versus perioperative ch...
Prof John Reynolds - Trinity College Dublin, Dublin, Republic of Ireland
COSMIC-311: Cabozantinib versus placebo in patients with radioiodine-refractory ...
Dr Marcia Brose - University of Pennsylvania, Philadelphia, USA
The clinical value of maintenance in multiple myeloma
Prof Wee Joo Chng - National University of Singapore, Singapore
Once weekly selinexor, carfilzomib, and dexamethasone (XKD) in carfilzomib non-r...
Prof Cristina Gasparetto - Duke Cancer Institute, Durham, USA